The 25th Bangkok International Symposium on HIV Medicine

Abstract

Proceedings of: 25th Bangkok International Symposium on HIV Medicine, 18–20 January 2023, held virtually and on site at Samyan Mitrtown Hall, Bangkok, Thailand.

The Bangkok International Symposium on HIV Medicine has commenced on the third Wednesday of January since 1998. The Symposium aims to provide professional healthcare workers in Thailand and the region an opportunity to receive the most up-to-date information on HIV and its related conditions if they are unable to attend other HIV conferences abroad. This year’s hybrid symposium was held from 18 January to 20 January 2023. A total of six plenary sessions were held in the mornings, and four afternoon workshops held on Wednesday and Thursday. Expert speakers from Thailand, China, Malaysia, Singapore, India, Hong Kong, the Philippines, Australia, the UK, The Netherlands and the USA participated in the symposium.

Keywords::

• aging
• comorbidities
• COVID-19
• hepatic diseases
• HIV
• prevention
• treatment
• tuberculosis

Acknowledgments

The authors thank all of the speakers for providing the latest information on HIV to the symposium, the chairpersons for coordinating with the speakers for the workshop, and the scientific committee for their advice in developing the program. Also, we would like to thank the Bangkok Symposium Team, especially K Nanthapisal, C Ruengpanyathip and E Phuengchangam.

Financial & competing interests disclosure

The 25th Bangkok International Symposium on HIV Medicine was supported by ViiV GSK, Gilead and DCH Auriga, Sysmex Asia Pacific Pte Ltd, Oxford Immunotec Limited, amfAR/TREAT Asia, Atlanta, Camber Pharmaceuticals, Cepheid, Abbott, The Government Pharmaceutical Organization (GPO), UNSW Kirby Institute and Thailand Convention and Exhibition Bureau (TCEB). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

The 25th Bangkok International Symposium on HIV Medicine was supported by ViiV GSK, Gilead and DCH Auriga, Sysmex Asia Pacific Pte Ltd, Oxford Immunotec Limited, amfAR/TREAT Asia, Atlanta, Camber Pharmaceuticals, Cepheid, Abbott, The Government Pharmaceutical Organization (GPO), UNSW Kirby Institute and Thailand Convention and Exhibition Bureau (TCEB). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.